EASL position paper on palliative care in advanced chronic liver disease
Abstract
Deaths from advanced chronic liver disease have increased significantly across Europe, with most affected patients not receiving a liver transplant. Despite this increasing burden, inequities in the provision of palliative care persist. Many patients are referred to specialist palliative care only in the final days or weeks of life and may continue to undergo futile invasive procedures. Drawing on the best available evidence, this position paper offers guidance to clinicians on the provision of palliative care to patients with advanced chronic liver disease, with the aim of improving the quality of life of this vulnerable cohort.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.